(Q40902534)

24 September 2017

1 reference

title

Directly observed therapy in New York City. History, implementation, results, and challenges (English)

1 reference

24 September 2017

3

Frieden TR

1 reference

24 September 2017

Fujiwara PI

1

1 reference

PubMed ID

9098618

24 September 2017

Larkin C

series ordinal

2

1 reference

24 September 2017

1 March 1997

1 reference

Clinics in Chest Medicine

24 September 2017

1 reference

24 September 2017

18

1 reference

24 September 2017

1

1 reference

24 September 2017

135-148

1 reference

Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

The prognosis of a positive tuberculin reaction in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

1 reference

7 January 2021

Tuberculosis in New York City--turning the tide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

The emergence of drug-resistant tuberculosis in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

Laboratory aspects of intermittent drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

Drug-resistant tuberculosis: issues in epidemiology and challenges for public health

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

Compliance: Inducements and Enforcements

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970363-4

7 January 2021

10.1016/S0272-5231(05)70363-4

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9098618